| Analysis of circulating tumor DNA to monitor metastatic breast cancer SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ... New England Journal of Medicine 368 (13), 1199-1209, 2013 | 2458 | 2013 |
| Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ... Nature 497 (7447), 108-112, 2013 | 1900 | 2013 |
| The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ... Nature communications 7 (1), 1-16, 2016 | 1543 | 2016 |
| The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ... Nature communications 7 (1), 1-16, 2016 | 1539 | 2016 |
| Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA T Forshew, M Murtaza, C Parkinson, D Gale, DWY Tsui, F Kaper, ... Science translational medicine 4 (136), 136ra68-136ra68, 2012 | 1528 | 2012 |
| Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 … FM Blows, KE Driver, MK Schmidt, A Broeks, FE Van Leeuwen, ... PLoS medicine 7 (5), e1000279, 2010 | 1245 | 2010 |
| Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ... The lancet oncology 15 (4), 406-414, 2014 | 923 | 2014 |
| Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ... Annals of oncology 25 (8), 1536-1543, 2014 | 808 | 2014 |
| CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity ML Burr, CE Sparbier, YC Chan, JC Williamson, K Woods, PA Beavis, ... Nature 549 (7670), 101-105, 2017 | 738 | 2017 |
| BET inhibitor resistance emerges from leukaemia stem cells CY Fong, O Gilan, EYN Lam, AF Rubin, S Ftouni, D Tyler, K Stanley, ... Nature 525 (7570), 538-542, 2015 | 510 | 2015 |
| Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ... Nature communications 6 (1), 8760, 2015 | 508 | 2015 |
| An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer ML Burr, CE Sparbier, KL Chan, YC Chan, A Kersbergen, EYN Lam, ... Cancer cell 36 (4), 385-401. e8, 2019 | 422 | 2019 |
| Ibrutinib plus venetoclax for the treatment of mantle-cell lymphoma CS Tam, MA Anderson, C Pott, R Agarwal, S Handunnetti, RJ Hicks, ... New England journal of medicine 378 (13), 1211-1223, 2018 | 414 | 2018 |
| A new genome‐driven integrated classification of breast cancer and its implications SJ Dawson, OM Rueda, S Aparicio, C Caldas The EMBO journal 32 (5), 617-628, 2013 | 389 | 2013 |
| BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received SJ Dawson, N Makretsov, FM Blows, KE Driver, E Provenzano, ... British journal of cancer 103 (5), 668-675, 2010 | 367 | 2010 |
| Non-genetic mechanisms of therapeutic resistance in cancer JC Marine, SJ Dawson, MA Dawson Nature Reviews Cancer 20 (12), 743-756, 2020 | 355 | 2020 |
| Triple negative breast cancers: clinical and prognostic implications SJ Dawson, E Provenzano, C Caldas European journal of cancer 45, 27-40, 2009 | 354 | 2009 |
| PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes HR Ali, SE Glont, FM Blows, E Provenzano, SJ Dawson, B Liu, L Hiller, ... Annals of Oncology 26 (7), 1488-1493, 2015 | 322 | 2015 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 307 | 2015 |
| Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation O Gilan, I Rioja, K Knezevic, MJ Bell, MM Yeung, NR Harker, EYN Lam, ... Science 368 (6489), 387-394, 2020 | 298 | 2020 |
